One approach could be to develop drugs that can bind tightly to the receptors on immune cells and induce the production of the anti-inflammatory IL-10.
This binding process stimulates production of a protein called interleukin-10 (IL-10) that acts as an anti-inflammatory compound and which helps keep the immune system's response to the infection in check.